Depression of the inotropic action of isoprenaline by nitric oxide synthase induction in rat isolated hearts

European Journal of Pharmacology

Volumn 320, Issue 1, 1997, Pages 29-35

  Sun, Xiaolu ^a   Wei, Shan ^a   Szabo, Csaba ^b   Dusting, Gregory J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Adrenoceptor; Dexamethasone; Endotoxin; Mercaptoethylguanidine; Myocardial contractility; Nitric oxide (NO) synthase

Indexed keywords

BETA ADRENERGIC RECEPTOR; DEXAMETHASONE; ENDOTOXIN; GUANIDINE DERIVATIVE; ISOPRENALINE; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; HEART MUSCLE CONTRACTILITY; INOTROPISM; INTRAPERITONEAL DRUG ADMINISTRATION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; BLOTTING, WESTERN; CARDIOTONIC AGENTS; CORONARY CIRCULATION; DEPRESSION, CHEMICAL; DEXAMETHASONE; ENZYME INDUCTION; ESCHERICHIA COLI; GUANIDINES; HEART; ISOPROTERENOL; LIPOPOLYSACCHARIDES; MALE; MYOCARDIAL CONTRACTION; NITRIC OXIDE SYNTHASE; NITROARGININE; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR PRESSURE;

EID: 0031046023     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00878-3     Document Type: Article

References (42)

1. Balligand, J.L., D. Ungureanu, R.A. Kelly, L. Kobzik, D. Pimental, T. Michel and T.W. Smith, 1993a, Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium, J. Clin. Invest. 91, 2314.
2. Balligand, J.L., R.A. Kelly, P.A. Marsden, T.W. Smith and T. Michel, 1993b, Control of cardiac muscle cell function by an endogenous nitric oxide signaling system, Proc. Natl. Acad. Sci. USA 90, 347.
3. Beckman, J.S., T.W. Beckman, J. Chen, P.A. Marshall and B.A. Freeman, 1990, Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide, Proc. Natl. Acad. Sci. USA 87, 1620.
4. Bhagat, B., D. Cavanaugh, B.N. Merrild, M.W. Rana and P.S. Roa, 1970, Noradrenaline and tyramine action on isolated atrial muscle of endotoxin-treated guinea-pigs, Br. J. Pharmacol. 39, 688.
5. Boucher, M., C. Dukbray and P. Duchene-Marullaz, 1984, Pharmacological evidence for differences in the beta-adrenoceptor populations mediating atrial and ventricular chronotropic responses in the unanesthetized dog, J. Auton. Pharmacol. 4, 279.
6. Brady, A.J., P.A. Poole Wilson, S.E. Harding and J.B. Warren, 1992, Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia, Am. J. Physiol. 263, H1963.
7. Deyton, L.R., R.E. Walker, J.A. Kovacs, B. Herpin, M. Parker, H. Masur, A.S. Fauci and C.H. Lane, 1989, Reversible cardiac dysfunction associated with interferon alpha therapy in AIDS patients with Kaposi's sarcoma, New Engl. J. Med. 321, 1246.
8. Ferguson, D.M. and A.J. Vazquez, 1984, Pharmacodynamic differentiation of chronotropic and inotropic beta-adrenergic receptors in rabbit heart, J. Cardiovasc. Pharmacol. 6, 151.
9. Finkel, M.S., C.V. Oddis, T.D. Jacob, S.C. Watkins, B.G. Hattler and R.L. Simmons, 1992, Negative inotropic effects of cytokines on the heart mediated by nitric oxide, Science 257, 387.
10. Fish, R.E., A.H. Burns, C.H. Lang and J.A. Spitzer, 1985, Myocardial dysfunction in a non-lethal, non-shock model of chronic endotoxemia, Circ. Shock 16, 241.
11. Garvey, E.P., J.A. Oplinger, G.J. Tanoury, P.A. Sherman, M. Fowler, S. Marshall, M.F. Harmon, J.E. Paith and E.S. Furfine, 1994, Potent and selective inhibition of human nitric oxide synthases, J. Biol. Chem. 269, 26669.
12. Grace, G.C., P.S. MacDonald and G.J. Dusting, 1988, Cyclic nucleotide interactions involved in endothelium-dependent dilatation in rat aortic rings, Eur. J. Pharmacol. 148, 17.
13. Gross, S.S., E.A. Jaffe, R. Levi and R.G. Kilbourn, 1991, Cytokine-activited endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activited macrophages, Biochem. Biophys. Res. Commun. 187, 823.
14. Gulick, T., M.K. Chung, S.J. Pieper, L.G. Lange and G.F. Schreiner, 1989, Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness, Proc. Natl. Acad. Sci. USA 86, 6753.
15. Hung, J. and W.Y. Lew, 1993, Cellular mechanisms of endotoxin-induced myocardial depression in rabbits, Circ. Res. 73, 125.
16. Kadowitz, P.J. and A.C. Yard, 1970, Circulatory effects of hydrocortisone and protection against endotoxin shock in cats, Eur. J. Pharmacol. 9, 311.
17. Kelly, R.A., J.L. Balligand and T.W. Smith, 1996, Nitric oxide and cardiac function, Circ. Res. 79, 363.
18. Kilbourn, R.G. and O.W. Griffith, 1992, Overproduction of nitric oxide in cytokine-mediated and septic shock, J. Natl. Cancer Inst. 84, 827.
19. Kutner, F.R. and J. Cohen, 1966, Effect of endotoxin on isolated cat papillary muscle, J. Surg. Res. 6, 83.
20. Lambert, L.E., J.P. Whitten, B.M. Beron, H.C. Cheng, N.S. Doherty and I.A. McDonald, 1991, Nitric oxide synthesis in CNS, endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues, Life Sci. 48, 69.
21. Macnicol, M.F., A.H. Goldberg and G.H. Clowes Jr., 1973, Depression of isolated heart muscle by bacterial endotoxin, J. Trauma 13, 554.
22. Misko, T.P., W.M. Moore, T.P. Kasten, D.A. Nickols, J.A. Corbett, R.G. Tilton, M.L. Mcdaniel, J.R. Williamson and M.G. Currie, 1993, Selective inhibition of the inducible NO synthase by aminoguanidine, Eur. J. Pharmacol. 233, 119.
23. Nora, R., J.S. Abrams, N.S. Tait, D.J. Hiponia and H.J. Silverman, 1989, Myocardial toxic effects during recombinant interleukin-2 therapy, J. Natl. Cancer Inst. 81, 59.
24. Parker, J.L. and H.R. Adams, 1979, Myocardial effects of endotoxin shock: characterization of an isolated heart muscle model, Adv. Shock Res. 2, 163.
25. Parker, M.M., J.H. Shelhamer, S.L. Bacharach, M.V. Green, C. Natanson, T.M. Frederick, B.A. Damske and J.E. Parillo, 1984, Profound but reversible myocardial depression in patients with septic shock, Ann. Intern. Med. 100, 483.
26. Parker, M.M., K.E. McCarthy, F.P. Ognibene and J.E. Parillo, 1990, Right ventricular dysfunction and dilatation similar to left ventricular changes, characterize the cardiac depression of septic shock in humans, Chest 97, 126.
27. Romano, F.D. and S.B. Jones, 1986, Alteration in β-adrenergic stimulation of myocardial adenylate cyclase in endotoxic rats, Am. J. Physiol. 250, R358.
28. Romanosky, A.J., M.E. Giaimo, R.E. Shepherd and A.H. Burns, 1986, The effect of in vivo endotoxin on myocardial function in vitro, Circ. Shock 19, 1.
29. Schulz, R. and R. Wambolt, 1995, Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury, Cardiovasc. Res. 30, 432.
30. 2+-independent nitric oxide synthase in the myocardium, Br. J. Pharmacol. 105, 575.
31. Schulz, R., D.L. Panas, R. Catena, S. Moncada, P.M. Olley and G.D. Lopaschuk, 1995, The role of nitric oxide in cardiac depression induced by interleukin-1ν and tumour necrosis factor-α, Br. J. Pharmacol. 114, 27.
32. Shen, W., T.H. Hintze and M.S. Wolin, 1995, Nitric oxide: an important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption, Circulation 92, 3505.
33. Shepherd, R.E., K.H. McDonough and A.H. Burns, 1986, Mechanisms of cardiac dysfunction in hearts from endotoxin-treated rats, Circ. Shock 19, 371.
34. Smith, L.W. and K.H. McDonough, 1988, Inotropic sensitivity to β-adrenergic stimulation in early sepsis, Am. J. Physiol. 255, H699.
35. Sobotka, P.A., J. McMannis, R. Fisher, D.G. Stein and J.X. Thomas Jr., 1990, Effects of interleukin-2 on cardiac function in the isolated rat heart, J. Clin. Invest. 86, 845.
36. Solis, R.T. and S.E. Downing, 1966, Effects of E. coli endotoxemia on ventricular performance, Am. J. Physiol. 211, 307.
37. Southan, G.J., A.L. Salzman and C. Szabó, 1995, Mercaptoalkylguanidines: a novel class of inhibitors of the inducible isoform of nitric oxide synthase, FASEB J. 9, A28.
38. Southan, G.J., B. Zingarelli, M. O'Connor, A.L. Salzman and C. Szabó, 1996, Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform, Br. J. Pharmacol. 117, 619.
39. Sufferedini, A.F., R.E. Fromm, M.M. Parker, M. Brenner, J.A. Kovacs, R.A. Wesley and J.E. Parrillo, 1989, The cardiovascular response of normal humans to the administration of endotoxin, New Engl. J. Med. 321, 280.
40. Szabó, C., 1995, Alterations in nitric oxide production in various forms of circulatory shock, New Horizons 3, 2.
41. Szabó, C., J.A. Mitchell, C. Thiemermann and J.R. Vane, 1993, Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthases in endotoxin shock, Br. J. Pharmacol. 108, 786.
42. Szabó, C., A.L. Salzman and H. Ischiropoulos, 1995, Peroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion, FEBS Lett. 372, 229.